Roche NimbleGen Seeks GMP Compliance for Arrays as Step Toward FDA Submission

"Cytogenetics is one of the first areas where there is interest to move beyond the current research studies, which will require an FDA cleared or approved product," said a Roche NimbleGen official.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.